MarginsXMarginsX
Home › Markets › Health Care › PPBT

Purple Biotech Ltd. (PPBT)

PPBT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.68
+3.70% on the day
Market cap
$2.7M
Nano cap
Revenue · 2020
$1.0M
0.0% on 2019
Net income · 2020
$28.7M
2870.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), fiscal year ended 2020-12-31, https://www.sec.gov/Archives/edgar/data/1614744/000121390023017024/0001213900-23-017024-index.htm. Net income: SEC 20-F (us-gaap:ProfitLoss), fiscal year ended 2020-12-31.

Profile

FieldValue
TickerPPBT on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryIsrael
IPO year2015
SEC CIK0001614744
SEC industry codePharmaceutical Preparations
Incorporated inIsrael

Financials · 2020

LineValue
Revenue$1.0M
Net income$28.7M
Operating income-$12.6M
Net margin2870.1%
Operating margin-1261.2%
Revenue growth0.0%
Cash$11.2M
Total assets$83.8M
P/E (computed)0.1×
P/S (computed)2.7×

Warning signs

Cash runway
18.5 months
$8.7M cash at December 31, 2025
Share count, 1 year
+3494.7%
2024-12-31 to 2025-12-31 · +201064.5% over 3 years
Going-concern doubt
No
20-F filed March 19, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-03-19
Cash and burn$8.7M cash; operating cash flow -$1.4M a quarter.Report 2025-12-31
Shares outstanding929,456 (2025-12-31); 258,564 a year earlier; 92,408 three years earlier. 1y figure adjusted for splits (1-for-10 overall); 3y figure adjusted for splits (1-for-200 overall); the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 years2; latest 1-for-10 on 2026-03-02Source 2026-03-02
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-05-20
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorSomekh Chaikin, Tel Aviv, IsraelPCAOB Form AP 2026-04-23
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30
Market cap checkThe listing's market cap implies 1,626,867 shares at the 2026-11-13 price; the latest SEC cover count is 929,456 as of 2025-12-31. The SEC count is the older of the two, so the listing's cap is likely the current one; shares were issued since that cover page.Nasdaq screener and SEC cover page

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
Not filed-$26.4M-$5.7M$8.7MNo debt tagsNeeds four quarters20-F 2026-03-19
FY 2024
2024-12-31
Not filed-$7.2M-$14.4M$7.4MNo debt tagsNeeds four quarters20-F 2026-03-19
FY 2023
2023-12-31
Not filed-$19.9M-$19.9M$14.5MNo debt tagsNeeds four quarters20-F 2026-03-19
FY 2022
2022-12-31
Not filed-$21.7M-$16.7M$15.0MNo debt tagsNeeds four quarters20-F 2025-03-10
FY 2021
2021-12-31
Not filed$17.8M-$374K$10.9MNo debt tagsNeeds four quarters20-F 2022-03-09
FY 2020
2020-12-31
$1.0M$28.7M$1.7M$11.2MNo debt tags$1.0M20-F 2023-03-03
FY 2019
2019-12-31
$1.0M$5.4M-$2.0M$4.4MNo debt tags$1.0M20-F 2021-03-16
FY 2018
2018-12-31
$1.0M$5.2M-$8.5M$5.2MNo debt tags$1.0M20-F 2021-03-16

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
REGISTRATION STATEMENT
F-32026-05-20
Latest annual report
ANNUAL REPORT
20-F2026-03-19
Latest quarterly / interim
REPORT OF FOREIGN PRIVATE ISSUER
6-K2026-10-05

Source: SEC EDGAR submissions feed, 580 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+24.4%
1 month+19.9%
3 months+9.0%
Year to date-75.2%
1 year-78.0%
From 52-week high-81.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
EOCNEocene Ltd.$2.53+5.86%$2.6M
ERNAErnexa Therapeutics Inc.$1.69+0.60%$2.9M
REVBRevelation Biosciences Inc.$3.82-10.43%$2.6M
GNPXGenprex Inc.$1.90-8.65%$2.5M
DRMADermata Therapeutics Inc.$0.5985-3.65%$3.0M
NRSNNeuroSense Therapeutics Ltd.$1.56-7.40%$3.0M
MBIOMustang Bio Inc.$0.3947-6.34%$3.0M
GRIGRI Bio Inc.$1.40-18.60%$3.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier